18 November 2021

This hour-long workshop, hosted by One Nucleus and facilitated by tranScrip's Paul Branthwaite, covered the fundamentals of drug development programmes, the main considerations and their evolution as biotechs mature their pre-clinical data.

This session is specifically dedicated to early stage companies who need to demonstrate their understanding of the underlying principles of drug development to their stakeholders, including mapping ROI for Target Drug Profile or costing the development plan.

You can view all One Nucleus' recordings here